Study title: A Double-Blind, Double-Dummy, Placebo-controlled 13-Week Comparison of ICI 204,219 (20 mg BID) with Sodium Cromoglycate in Patients with Mild to Moderate Asthma
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: ZAFIRLUKAST | |||||
| ATC code: R03DC01 | |||||
| Document link: 9188IL0059 Summary.pdf | |||||
| Document date: 2011-09-13 | |||||
| Study number: 9188IL/0059 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |